Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced the upcoming presentation of two...
-
Mar 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Barclays 26th Annual Global Healthcare Conference on Wednesday,...
-
Mar 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized cross-over study comparing lower extremity lymphedema treatment...
-
Mar 5, 2024Mobile World Congress Exhibitor News, photos, videos and more
On February 27th, the China Telecom Cloud and Connectivity Summit was successfully held at the grand 2024 Mobile World Congress (MWC2024) in Barcelona. With the theme of " Leading the...
-
Mar 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting Nectin-4, KRAS G12D, and BRM (SMARCA2) will be presented at the American Association for Cancer...
-
Mar 5, 2024Virtual Press Office and PR Newswire: General Trade show news
-- Data support ongoing development of antibody-drug conjugate (ADC) program targeting HER3-expressing cancers – -- On-track to nominate development candidate in 2024 -- BOSTON, March 5, 2024...
-
Mar 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that interim...
-
Mar 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Preclinical data demonstrate presence of CD161 expressing T cells in anti-PD1 non-responder tumors and enhanced T cell mediated cytotoxicity with combination treatment of IMT-009 and anti-PD1,...
-
Mar 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR-driven cancers, today announced poster...
-
Mar 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage immunology company, today announced it will be providing updates on its RNA immunotherapies at multiple presentations at the American...